• Je něco špatně v tomto záznamu ?

Association of depressive symptoms with incidence and mortality rates of COVID-19 over 2 years among healthcare workers in 20 countries: multi-country serial cross-sectional study

H. Asaoka, K. Watanabe, Y. Miyamoto, A. Restrepo-Henao, E. van der Ven, MF. Moro, LA. Alnasser, O. Ayinde, AA. Balalian, A. Basagoitia, S. Durand-Arias, M. Eskin, E. Fernández-Jiménez, FFM. Ines, L. Giménez, HW. Hoek, RE. Jaldo, J. Lindert, H....

. 2024 ; 22 (1) : 386. [pub] 20240912

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc24018922

BACKGROUND: Long-term deterioration in the mental health of healthcare workers (HCWs) has been reported during and after the COVID-19 pandemic. Determining the impact of COVID-19 incidence and mortality rates on the mental health of HCWs is essential to prepare for potential new pandemics. This study aimed to investigate the association of COVID-19 incidence and mortality rates with depressive symptoms over 2 years among HCWs in 20 countries during and after the COVID-19 pandemic. METHODS: This was a multi-country serial cross-sectional study using data from the first and second survey waves of the COVID-19 HEalth caRe wOrkErS (HEROES) global study. The HEROES study prospectively collected data from HCWs at various health facilities. The target population included HCWs with both clinical and non-clinical roles. In most countries, healthcare centers were recruited based on convenience sampling. As an independent variable, daily COVID-19 incidence and mortality rates were calculated using confirmed cases and deaths reported by Johns Hopkins University. These rates represent the average for the 7 days preceding the participants' response date. The primary outcome was depressive symptoms, assessed by the Patient Health Questionnaire-9. A multilevel linear mixed model (LMM) was conducted to investigate the association of depressive symptoms with the average incidence and mortality rates. RESULTS: A total of 32,223 responses from the participants who responded to all measures used in this study on either the first or second survey, and on both the first and second surveys in 20 countries were included in the analysis. The mean age was 40.1 (SD = 11.1), and 23,619 responses (73.3%) were from females. The 9323 responses (28.9%) were nurses and 9119 (28.3%) were physicians. LMM showed that the incidence rate was significantly and positively associated with depressive symptoms (coefficient = 0.008, standard error 0.003, p = 0.003). The mortality rate was significantly and positively associated with depressive symptoms (coefficient = 0.049, se = 0.020, p = 0.017). CONCLUSIONS: This is the first study to show an association between COVID-19 incidence and mortality rates with depressive symptoms among HCWs during the first 2 years of the outbreak in multiple countries. This study's findings indicate that additional mental health support for HCWs was needed when the COVID-19 incidence and mortality rates increase during and after the early phase of the pandemic, and these findings may apply to future pandemics. TRIAL REGISTRATION: Clinicaltrials.gov, NCT04352634.

Centro de Investigación Biomédica en Red de Salud Mental Instituto de Salud Carlos 3 Madrid Spain

Columbia University Mailman School of Public Health New York NY USA

Department of Biostatistics Mailman School of Public Health Columbia University New York NY USA

Department of Child and Adolescent Psychiatry NYU Langone Health New York USA

Department of Clinical Neuro and Developmental Psychology Vrije Universiteit Amsterdam Amsterdam The Netherlands

Department of Epidemiology 2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Epidemiology Columbia University Mailman School of Public Health New York USA

Department of Mental Health Graduate School of Medicine The University of Tokyo 7 3 1 Hongo Bunkyoku Tokyo 113 0033 Japan

Department of Population Health King Abdullah International Medical Research Center Ministry of National Guard Riyadh Saudi Arabia

Department of Psychiatric Nursing Graduate School of Medicine The University of Tokyo Tokyo Japan

Department of Psychiatry Clinical Psychology and Mental Health La Paz University Hospital Madrid Spain

Department of Psychiatry Universidad Autónoma de Madrid Madrid Spain

Department of Psychiatry University Medical Center Groningen University of Groningen Groningen The Netherlands

Department of Psychiatry University of Ibadan Ibadan Nigeria

Department of Psychology Koc University Istanbul Turkey

Department of Public Health Kitasato University School of Medicine Sagamihara Japan

Department of Public Health School of Medicine Universidad Nacional de Colombia Bogotá Colombia

Department Psychiatry A Razi Hospital La Manouba Manouba Tunisia

Dirección de Salud Mental Ministerio de Salud Lima Peru

Escuela de Salud Pública CL Faculty of Medicine University of Chile Santiago Chile

Escuela de Salud Social y Comunitaria Universidad del Chubut Chubut Argentina

Faculty of Health and Social Work University of Applied Sciences Emden Leer Emden Germany

Faculty of Medicine Federal University of Pelotas Pelotas Brazil

Faculty of Medicine of Tunis University of Tunis El Manar Tunis Tunisia

Faculty of Medicine University of São Paulo São Paulo Brazil

Faculty of Social Sciences and Communication Universidad Europea de Madrid Madrid Spain

Graduate Education Division Universidad El Bosque Bogotá Colombia

Harvard T H Chan School of Public Health Harvard University Cambridge USA

Health Psychology Institute Faculty of Psychology University of the Republic Montevideo Uruguay

Hospital La Paz Institute for Health Research Madrid Spain

Instituto Altos Estudios Dr Arnoldo Gabaldon Maracay Venezuela

Instituto de Investigación del Hospital Universitario La Princesa Madrid Spain

Instituto Nacional de Psiquiatría Ramón de La Fuente Muñiz Mexico City Mexico

Interdisciplinary Centre for Health Studies Department of Public Health School of Medicine Faculty of Medicine Universidad de Valparaíso Valparaíso Chile

Medical Intensive Care Abderrahmen Mami Hospital Aryanah Tunisia

National Institute of Health Named After Academician S Avdalbekyan Yerevan Armenia

National School of Public Health Universidad de Antioquia Medellín Colombia

New York State Psychiatric Institute New York USA

Parnassia Psychiatric Institute Parnassia Groep The Hague the Netherlands

Question Driven Design and Analysis Group New York USA

Research Science and Technology Direction Universidad San Francisco Xavier de Chuquisaca Sucre Bolivia

Salud Global Bolivia La Paz Bolivia

School of Medicine University of San Carlos of Guatemala Guatemala City Guatemala

Universidad del Chubut Escuela de Salud Social y Comunitaria Chubut Argentina

Università Degli Studi Di Cagliari Cagliari Italy

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24018922
003      
CZ-PrNML
005      
20241024111107.0
007      
ta
008      
241015s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12916-024-03585-8 $2 doi
035    __
$a (PubMed)39267052
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Asaoka, Hiroki $u Department of Mental Health, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyoku, Tokyo, 113-0033, Japan
245    10
$a Association of depressive symptoms with incidence and mortality rates of COVID-19 over 2 years among healthcare workers in 20 countries: multi-country serial cross-sectional study / $c H. Asaoka, K. Watanabe, Y. Miyamoto, A. Restrepo-Henao, E. van der Ven, MF. Moro, LA. Alnasser, O. Ayinde, AA. Balalian, A. Basagoitia, S. Durand-Arias, M. Eskin, E. Fernández-Jiménez, FFM. Ines, L. Giménez, HW. Hoek, RE. Jaldo, J. Lindert, H. Maldonado, G. Martínez-Alés, R. Mediavilla, C. McCormack, J. Narvaez, U. Ouali, A. Barrera-Perez, E. Calgua-Guerra, J. Ramírez, AM. Rodríguez, D. Seblova, ATC. da Silva, L. Valeri, O. Gureje, D. Ballester, MG. Carta, A. Isahakyan, A. Jamoussi, J. Seblova, MT. Solis-Soto, R. Alvarado, E. Susser, F. Mascayano, D. Nishi, HEROES group
520    9_
$a BACKGROUND: Long-term deterioration in the mental health of healthcare workers (HCWs) has been reported during and after the COVID-19 pandemic. Determining the impact of COVID-19 incidence and mortality rates on the mental health of HCWs is essential to prepare for potential new pandemics. This study aimed to investigate the association of COVID-19 incidence and mortality rates with depressive symptoms over 2 years among HCWs in 20 countries during and after the COVID-19 pandemic. METHODS: This was a multi-country serial cross-sectional study using data from the first and second survey waves of the COVID-19 HEalth caRe wOrkErS (HEROES) global study. The HEROES study prospectively collected data from HCWs at various health facilities. The target population included HCWs with both clinical and non-clinical roles. In most countries, healthcare centers were recruited based on convenience sampling. As an independent variable, daily COVID-19 incidence and mortality rates were calculated using confirmed cases and deaths reported by Johns Hopkins University. These rates represent the average for the 7 days preceding the participants' response date. The primary outcome was depressive symptoms, assessed by the Patient Health Questionnaire-9. A multilevel linear mixed model (LMM) was conducted to investigate the association of depressive symptoms with the average incidence and mortality rates. RESULTS: A total of 32,223 responses from the participants who responded to all measures used in this study on either the first or second survey, and on both the first and second surveys in 20 countries were included in the analysis. The mean age was 40.1 (SD = 11.1), and 23,619 responses (73.3%) were from females. The 9323 responses (28.9%) were nurses and 9119 (28.3%) were physicians. LMM showed that the incidence rate was significantly and positively associated with depressive symptoms (coefficient = 0.008, standard error 0.003, p = 0.003). The mortality rate was significantly and positively associated with depressive symptoms (coefficient = 0.049, se = 0.020, p = 0.017). CONCLUSIONS: This is the first study to show an association between COVID-19 incidence and mortality rates with depressive symptoms among HCWs during the first 2 years of the outbreak in multiple countries. This study's findings indicate that additional mental health support for HCWs was needed when the COVID-19 incidence and mortality rates increase during and after the early phase of the pandemic, and these findings may apply to future pandemics. TRIAL REGISTRATION: Clinicaltrials.gov, NCT04352634.
650    _2
$a lidé $7 D006801
650    12
$a COVID-19 $x mortalita $x epidemiologie $x psychologie $7 D000086382
650    _2
$a průřezové studie $7 D003430
650    12
$a zdravotnický personál $x psychologie $7 D006282
650    12
$a deprese $x epidemiologie $7 D003863
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a incidence $7 D015994
650    _2
$a dospělí $7 D000328
650    _2
$a lidé středního věku $7 D008875
650    _2
$a SARS-CoV-2 $7 D000086402
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Watanabe, Kazuhiro $u Department of Public Health, Kitasato University School of Medicine, Sagamihara, Japan
700    1_
$a Miyamoto, Yuki $u Department of Psychiatric Nursing, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
700    1_
$a Restrepo-Henao, Alexandra $u National School of Public Health Universidad de Antioquia, Medellín, Colombia
700    1_
$a van der Ven, Els $u Department of Clinical, Neuro- and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
700    1_
$a Moro, Maria Francesca $u Department of Epidemiology, Columbia University Mailman School of Public Health, New York, USA
700    1_
$a Alnasser, Lubna A $u Department of Population Health, King Abdullah International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Ministry of National Guard, Riyadh, Saudi Arabia
700    1_
$a Ayinde, Olatunde $u Department of Psychiatry, University of Ibadan, Ibadan, Nigeria
700    1_
$a Balalian, Arin A $u Question Driven Design and Analysis Group (QD-DAG), New York, USA
700    1_
$a Basagoitia, Armando $u Salud Global Bolivia, La Paz, Bolivia
700    1_
$a Durand-Arias, Sol $u Instituto Nacional de Psiquiatría Ramón de La Fuente Muñiz, Mexico City, Mexico
700    1_
$a Eskin, Mehmet $u Department of Psychology, Koc University, Istanbul, Turkey
700    1_
$a Fernández-Jiménez, Eduardo $u Department of Psychiatry, Clinical Psychology and Mental Health, La Paz University Hospital, Madrid, Spain $u Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain $u Faculty of Social Sciences and Communication, Universidad Europea de Madrid, Madrid, Spain
700    1_
$a Ines, Freytes Frey Marcela $u Universidad del Chubut, Escuela de Salud Social y Comunitaria, Chubut, Argentina
700    1_
$a Giménez, Luis $u Health Psychology Institute, Faculty of Psychology, University of the Republic, Montevideo, Uruguay
700    1_
$a Hoek, Hans W $u Department of Epidemiology, Columbia University Mailman School of Public Health, New York, USA $u Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands $u Parnassia Psychiatric Institute, Parnassia Groep, The Hague, the Netherlands
700    1_
$a Jaldo, Rodrigo Ezequiel $u Escuela de Salud Social y Comunitaria, Universidad del Chubut, Chubut, Argentina
700    1_
$a Lindert, Jutta $u Faculty of Health and Social Work, University of Applied Sciences Emden / Leer, Emden, Germany
700    1_
$a Maldonado, Humberto $u Dirección de Salud Mental, Ministerio de Salud, Lima, Peru
700    1_
$a Martínez-Alés, Gonzalo $u Harvard T.H. Chan School of Public Health, Harvard University, Cambridge, USA
700    1_
$a Mediavilla, Roberto $u Department of Psychiatry, Universidad Autónoma de Madrid, Madrid, Spain $u Instituto de Investigación del Hospital Universitario La Princesa, Madrid, Spain $u Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
700    1_
$a McCormack, Clare $u Department of Child and Adolescent Psychiatry, NYU Langone Health, New York, USA
700    1_
$a Narvaez, Javier $u Department of Public Health, School of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia $u Graduate Education Division, Universidad El Bosque, Bogotá, Colombia
700    1_
$a Ouali, Uta $u Department Psychiatry A, Razi Hospital La Manouba, Manouba, Tunisia $u Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia
700    1_
$a Barrera-Perez, Aida $u School of Medicine, University of San Carlos of Guatemala, Guatemala City, Guatemala
700    1_
$a Calgua-Guerra, Erwin $u School of Medicine, University of San Carlos of Guatemala, Guatemala City, Guatemala
700    1_
$a Ramírez, Jorge $u Escuela de Salud Pública CL, Faculty of Medicine, University of Chile, Santiago, Chile
700    1_
$a Rodríguez, Ana María $u Instituto Altos Estudios Dr Arnoldo Gabaldon, Maracay, Venezuela
700    1_
$a Seblova, Dominika $u Department of Epidemiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a da Silva, Andrea Tenorio Correia $u Faculty of Medicine, University of São Paulo, São Paulo, Brazil
700    1_
$a Valeri, Linda $u Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA
700    1_
$a Gureje, Oye $u Department of Psychiatry, University of Ibadan, Ibadan, Nigeria
700    1_
$a Ballester, Dinarte $u Faculty of Medicine, Federal University of Pelotas, Pelotas, Brazil
700    1_
$a Carta, Mauro Giovanni $u Università Degli Studi Di Cagliari, Cagliari, Italy
700    1_
$a Isahakyan, Anna $u National Institute of Health Named After Academician S. Avdalbekyan, Yerevan, Armenia
700    1_
$a Jamoussi, Amira $u Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia $u Medical Intensive Care, Abderrahmen Mami Hospital, Aryanah, Tunisia
700    1_
$a Seblova, Jana $u Department of Epidemiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Solis-Soto, Maria Teresa $u Research, Science and Technology Direction, Universidad San Francisco Xavier de Chuquisaca, Sucre, Bolivia
700    1_
$a Alvarado, Ruben $u Interdisciplinary Centre for Health Studies (CIESAL), Department of Public Health, School of Medicine, Faculty of Medicine, Universidad de Valparaíso, Valparaíso, Chile
700    1_
$a Susser, Ezra $u Columbia University Mailman School of Public Health, New York, NY, USA $u New York State Psychiatric Institute, New York, USA
700    1_
$a Mascayano, Franco $u Department of Epidemiology, Columbia University Mailman School of Public Health, New York, USA $u New York State Psychiatric Institute, New York, USA
700    1_
$a Nishi, Daisuke $u Department of Mental Health, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyoku, Tokyo, 113-0033, Japan. d-nishi@m.u-tokyo.ac.jp
710    2_
$a HEROES group
773    0_
$w MED00008190 $t BMC medicine $x 1741-7015 $g Roč. 22, č. 1 (2024), s. 386
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39267052 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024111100 $b ABA008
999    __
$a ok $b bmc $g 2201649 $s 1230895
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 22 $c 1 $d 386 $e 20240912 $i 1741-7015 $m BMC medicine $n BMC Med $x MED00008190
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Možnosti archivace